Seven Bridges Advisors’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Seven Bridges Advisors’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,033	Closed	-$541K	–	119
2017 Q4	$541K	Buy	+10,033	New	+$549K	0.44%	64

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Seven Bridges Advisors's BIVV Position: Q1 2018 in Review

Seven Bridges Advisors sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 10,033 shares — an estimated $541K sold.

Seven Bridges Advisors first reported a position in BIVV in Q4 2017 and held it in 1 quarter. The position peaked at $541K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Seven Bridges Advisors reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Seven Bridges Advisors sold 10,033 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $541K.
Seven Bridges Advisors first reported a position in Bioverativ Inc. Common Stock in Q4 2017 and held it in 1 quarter.
Seven Bridges Advisors's Bioverativ Inc. Common Stock position peaked at $541K in Q4 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Seven Bridges Advisors's 13F filing for Q1 2018, filed 9 May 2018.